Health Capital and private investors contribute €1 million in funding to the medical technology company Homed-IQ.In response to de Jonge’s experience with type 1 diabetes, Geert Brinkers and Robert de Jonge launched Homed-IQ in the Netherlands, exposing the complexity and ineffectiveness of conventional medical testing.
They were inspired to create an at-home medical diagnostics service and a top platform for comprehensive laboratory testing services.
Robert de Jonge, CEO of Homed-IQ said, “We are delighted to welcome an investment of EUR 1 million, which will enable us to realise our vision of accessible medical diagnostics further,”.
Homed-IQ provides a streamlined testing process and an array of top-notch self-administered health exams. It operates in Germany, Belgium, Austria, and the Netherlands.
Patients can monitor important health factors at home, including genetic data and blood markers, which helps in the early identification of likely disorders.
Douwe Jippes, co-founder and managing partner of Healthy Capital, shared:
“Homed-IQ plays a crucial role in transforming healthcare in Europe by combining innovation and accessibility. Through their advanced platform, they contribute to delivering sensible care, preventing unnecessary use of resources, alleviating staff shortages, and improving working processes in the health sector.”
Geert Brinkers and Robert de Jonge, two friends from college, launched Homed-IQ, a business that offers at-home medical testing. When Robert was given a type 1 diabetes diagnosis in 2019, the company’s adventure really began. This diagnosis profoundly changed Robert’s perception of what contemporary, easily accessible health care should entail because he was a happy father of four with no prior health issues.
From that point on, he needed constantly monitor his blood glucose level, which necessitated periodic blood tests. He also became insulin-dependent. These tests prompted Robert to travel to a different town and spend several hours of his day performing an operation that only needed a little amount of blood.
This encounter opened his eyes to the possible complexity and inefficiencies of the current medical testing system, prompting him to think of testing solutions that were simpler to use and more readily available to patients.